Evoke Pharma Return on Investment 2012-2024 | EVOK
Current and historical return on investment (ROI) values for Evoke Pharma (EVOK) over the last 10 years.
Evoke Pharma ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2024-09-30 |
$-0.01B |
|
inf% |
2024-06-30 |
$-0.01B |
|
-700.00% |
2024-03-31 |
$-0.01B |
|
-320.00% |
2023-12-31 |
$-0.01B |
|
-188.24% |
2023-09-30 |
$-0.01B |
$0.00B |
-123.08% |
2023-06-30 |
$-0.01B |
$0.01B |
-96.97% |
2023-03-31 |
$-0.01B |
$0.01B |
-82.05% |
2022-12-31 |
$-0.01B |
$0.01B |
-82.05% |
2022-09-30 |
$-0.01B |
$0.01B |
-82.05% |
2022-06-30 |
$-0.01B |
$0.01B |
-84.21% |
2022-03-31 |
$-0.01B |
$0.01B |
-86.49% |
2021-12-31 |
$-0.01B |
$0.01B |
-83.72% |
2021-09-30 |
$-0.01B |
$0.01B |
-100.00% |
2021-06-30 |
$-0.01B |
$0.01B |
-138.46% |
2021-03-31 |
$-0.01B |
$0.01B |
-329.41% |
2020-12-31 |
$-0.01B |
$0.00B |
-1300.00% |
2020-09-30 |
$-0.01B |
$0.00B |
-2400.00% |
2020-06-30 |
$-0.01B |
$0.00B |
-2400.00% |
2020-03-31 |
$-0.01B |
|
inf% |
2019-12-31 |
$-0.01B |
|
inf% |
2019-09-30 |
$-0.01B |
|
inf% |
2019-06-30 |
$-0.01B |
|
inf% |
2019-03-31 |
$-0.01B |
|
inf% |
2018-12-31 |
$-0.01B |
|
inf% |
2018-09-30 |
$-0.01B |
|
inf% |
2018-06-30 |
$-0.01B |
|
inf% |
2018-03-31 |
$-0.01B |
|
inf% |
2017-12-31 |
$-0.01B |
|
inf% |
2017-09-30 |
$-0.01B |
|
inf% |
2017-06-30 |
$-0.01B |
|
inf% |
2017-03-31 |
$-0.01B |
|
inf% |
2016-12-31 |
$-0.01B |
|
-1000.00% |
2016-09-30 |
$-0.01B |
|
-366.67% |
2016-06-30 |
$-0.01B |
|
-218.18% |
2016-03-31 |
$-0.01B |
$0.00B |
-165.52% |
2015-12-31 |
$-0.01B |
$0.01B |
-137.14% |
2015-09-30 |
$-0.01B |
$0.01B |
-120.00% |
2015-06-30 |
$-0.01B |
$0.01B |
-173.33% |
2015-03-31 |
$-0.01B |
$0.01B |
-226.09% |
2014-12-31 |
$-0.01B |
$0.01B |
-157.58% |
2014-09-30 |
$-0.01B |
|
-111.63% |
2014-06-30 |
$-0.01B |
|
-50.00% |
2014-03-31 |
$-0.01B |
$0.02B |
-31.25% |
2013-12-31 |
$-0.00B |
$0.02B |
-18.18% |
2013-06-30 |
$0.00B |
$0.00B |
nan% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.006B |
$0.005B |
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|